Table 1.
Patient Characteristic | Mean (SD) or Frequency (%) |
---|---|
Age (years) | 57.5 (12.3) |
Woman | 5 (100%) |
Race/ethnicity | |
Non-Hispanic white | 5 (100%) |
Education | |
2 years of college/AA/technical | 4 (80%) |
College graduate | 1 (20%) |
Annual household income | |
$50,000-$99,999 | 3 (60%) |
$100,000 or greater | 2 (40%) |
Current relationship status | |
Married or living with someone else | 5 (100%) |
Menopausal Status | |
Post-menopausal | 4 (80%) |
Breast cancer stage | |
Stage 0 | 1 (20%) |
Stage IA | 1 (20%) |
Stage IIA | 2 (40%) |
Stage IIB | 1 (20%) |
Type of adjuvant endocrine therapy | |
Letrozole | 2 (40%) |
Exemestane | 1 (20%) |
Anastrozole | 1 (20%) |
Tamoxifen | 1 (20%) |
Months since initiating adjuvant endocrine therapy (median; range) | 5 (1–12) |
Type of primary breast cancer treatment | |
Surgery only | 2 (40%) |
Surgery & Chemotherapy | 1 (20%) |
Surgery & Radiation | 1 (20%) |
Surgery, Chemotherapy, & Radiation | 1 (20%) |
Baseline Adherence Rate (Electronic Medical Event Monitoring System [MEMS Caps]) | 82.86% (38.33) |
Note: SD = Standard Deviation